
Advertisement
Cyclerion Therapeutics Inc closed the week at 3.92 USD, recording a remarkable gain of 1.14 points (41.01%) over the past five days. As of January 31 at 7:59 PM GMT-5, the stock showed strong positive movement.
In after-hours trading, the stock continued its upward trajectory, rising to 4.15 USD, an increase of 0.23 points (5.87%), suggesting ongoing investor confidence led by the announcement made by the company about converting 25% of its outstanding Series B Convertible Preferred Stock into common stock to streamline its balance sheet and reduce leverage.
During the regular session, Cyclerion reached a high of 4.47 USD, indicating strong demand and a peak in the stock’s performance. The low of 3.04 USD reflects intraday volatility. The opening price of 3.34 USD shows that the stock started the session at a relatively lower level before gaining momentum throughout the session. Cyclerion Therapeutics has a current evaluation of 1.06 Cr USD.
Disclaimer: This article is for informational purposes only and does not constitute any financial advice.